Analgesics in Vietnam is outperforming much of the Asia Pacific region in 2026, supported by robust consumer demand and favourable economic conditions. The environment remains highly attractive due to a population exceeding 102 million, expanding self-medication habits, and rising disposable incomes, but is increasingly defined by the growing power of pharmacy chains, digital integration, and a pronounced shift towards affordability and compliance. Strategic success is now contingent on building strong alliances with leading pharmacy chains, maintaining digital visibility, ensuring compliance with tightening regulations from July 2026, and delivering value-driven propositions to consumers who are both price sensitive and brand loyal. As the landscape consolidates around large players and regulatory standards rise, brands able to combine robust supply chains, competitive pricing, and broad access will capture the most sustained growth opportunities.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Vietnam with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Vietnam, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Vietnam report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Vietnam?
- Which are the leading brands in Analgesics in Vietnam?
- How are products distributed in Analgesics in Vietnam?
- How has the regulatory and operating environment for Analgesics changed in Vietnam?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Key Data Insights
Key Industry Trends
Long Chau expands reach, driving pricing power and consumer access
DHG Pharmaceutical leverages mass positioning to outpace premium brands
Chart 1 Value Sales 2021-2031
Chart 2 Value Sales by Category 2026
Pharmacy chains expected to leverage digital and regulatory shifts to drive repeat purchases
Systemic formats set to remain dominant while topical lines to accelerate
Chart 1 Forecast Value Sales 2021-2031
Chart 2 Forecast Value Sales by Category 2026-2031
Livzon acquisition enables Imexpharm to intensify price competition
Chart 1 Company Shares 2026
Chart 2 Brand Shares 2026
Pharmacy chains expand reach to secure stronger bargaining power
Chart 1 Retail Channels 2021-2026
Affordability and regulatory compliance shape the product innovation agenda
DHG Pharmaceutical and Imexpharm illustrate divergent paths through the affordability-premiumisation divide
Livzon's acquisition of Imexpharm restructures the competitive economics of generic analgesics
Chart 1 Real GDP Growth 2021-2031
Chart 2 Inflation 2021-2031
Chart 1 Population 2021-2031
Chart 2 Population by Generation 2026
Chart 3 Consumer Expenditure 2021-2031
Country Reports Disclaimer
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!